SEC Comment Letter for InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Jun 26, 2018
InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: June 26, 2018 · CIK: 0001433607 · Accession: 0000000000-18-019572
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225680
Letter
June 25, 2018 James Barry, Ph.D. President and Chief Executive Officer InspireMD, Inc. 4 Menorat Hamaor St. Tel Aviv, Israel 6744832 Re:InspireMD, Inc. Registration Statement on Form S-1 Filed June 15, 2018 File No. 333-225680 Dear Dr. Barry: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Thomas Jones at 202-551-3602 with any questions. Division of Corporation Finance Office of Electronics and Machinery cc: Rick A. Werner, Esq.
Show Raw Text
June 25, 2018
James Barry, Ph.D.
President and Chief Executive Officer
InspireMD, Inc.
4 Menorat Hamaor St.
Tel Aviv, Israel 6744832
Re:InspireMD, Inc.
Registration Statement on Form S-1
Filed June 15, 2018
File No. 333-225680
Dear Dr. Barry:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Thomas Jones at 202-551-3602 with any questions.
Division of Corporation Finance
Office of Electronics and Machinery
cc: Rick A. Werner, Esq.